株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の内視鏡およびラジオ波焼灼法(RFA)市場:応用分野(心臓、疼痛管理、腫瘍)、地域別 - 市場機会と産業予測 2017年~2025年

Endoscope + Radiofrequency Ablation (RFA) Market by Application (Cardiology, Applications, Pain Management, Oncology Applications, and Other Applications) - Global Opportunity Analysis and Industry Forecast, 2017-2025

発行 Allied Market Research 商品コード 677076
出版日 ページ情報 英文 75 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.51円で換算しております。
世界の内視鏡およびラジオ波焼灼法(RFA)市場:応用分野(心臓、疼痛管理、腫瘍)、地域別 - 市場機会と産業予測 2017年~2025年 Endoscope + Radiofrequency Ablation (RFA) Market by Application (Cardiology, Applications, Pain Management, Oncology Applications, and Other Applications) - Global Opportunity Analysis and Industry Forecast, 2017-2025
出版日: 2018年07月01日 ページ情報: 英文 75 Pages
概要

世界の内視鏡およびラジオ波焼灼法(RFA)市場は、2017年に35億6,740万米ドルと評価され、2018年から2025年にかけては9.6%のCAGRで推移し、2025年までに74億7,150万米ドル規模の市場に成長することが予測されています。

当レポートでは、世界の内視鏡およびラジオ波焼灼法(RFA)市場を調査し、市場の概要、応用分野・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 調査結果
  • CXOの視点

第3章 市場の概観

  • 市場の定義と範囲
  • 革新的な製品
    • バレックス
    • ハビブEUS RFAカテーテル
    • 耐熱プローブ
  • 臨床試験
  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会

第4章 内視鏡およびラジオ波焼灼法(RFA)市場:応用分野別

  • 概要
    • 市場規模と予測
  • 腫瘍
    • 市場規模と予測
  • 疼痛管理
    • 市場規模と予測
  • 心臓疾患
    • 市場規模と予測
  • その他
    • 市場規模と予測

第5章 企業プロファイル

  • Boston Scientific Corporation
  • Conmed Corporation
  • Medtronic Plc
  • Smith & Nephew Plc
  • Stryker Corporation
図表

List of Tables

  • TABLE 01. CLINICAL TRIALS, RADIOFREQUENCY ABLATION DEVICES MARKET, 2013-2016
  • TABLE 02. GLOBAL ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET, BY APPLICATION, 2017-2025 ($MILLION)
  • TABLE 03. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2017-2025 ($MILLION)
  • TABLE 04. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET FOR PAIN MANAGEMENT, BY REGION, 2017-2025 ($MILLION)
  • TABLE 05. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET FOR CARDIOLOGY APPLICATIONS, BY REGION, 2017-2025 ($MILLION)
  • TABLE 06. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2025 ($MILLION)
  • TABLE 07. BOSTON: COMPANY SNAPSHOT
  • TABLE 08. BOSTON: OPERATING SEGMENT
  • TABLE 09. CONMED: COMPANY SNAPSHOT
  • TABLE 10. CONMED: OPERATING SEGMENT
  • TABLE 11. MEDTRONC: COMPANY SNAPSHOT
  • TABLE 12. MEDTRONIC: OPERATING SEGMENT
  • TABLE 13. SMITH & NEPHEW: COMPANY SNAPSHOT
  • TABLE 14. SMITH: OPERATING SEGMENT
  • TABLE 15. STRYKER: COMPANY SNAPSHOT
  • TABLE 16. STRYKER: OPERATING SEGMENTS

List of Figures

  • FIGURE 01. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET SEGMENTATION
  • FIGURE 02. RECENT PRODUCT LAUNCHES
  • FIGURE 01. RESTRAINTS AND DRIVERS: GLOBAL ENDOSCOPE+RFA MARKET
  • FIGURE 02. GLOBAL ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET, 2017-2025 ($MILLION)
  • FIGURE 03. . ESTIMATED NEW CANCER CASES AND DEATHS, 2017: U.S.
  • FIGURE 04. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET FOR ONCOLOGY APPLICATIONS, 2017-2025 ($MILLION)
  • FIGURE 05. RADIOFREQUENCY ABLATION FOR CHRONIC PAIN MANAGEMENT
  • FIGURE 06. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET FOR PAIN MANAGEMENT, 2017-2025 ($MILLION)
  • FIGURE 07. FREQUENCY OF ATRIAL FIBRILLATION AMONG PATIENTS WITH ISCHEMIC STROKE, 2013-2014
  • FIGURE 08. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET FOR CARDIOLOGY APPLICATIONS, 2017-2025 ($MILLION)
  • FIGURE 09. ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET FOR OTHER APPLICATIONS, 2017-2025 ($MILLION)
  • FIGURE 10. BOSTON: NET SALES, 2015-2017($MILLION)
  • FIGURE 11. BOSTON: REVENUE SHARE PER SEGMENT 2017(%)
  • FIGURE 12. BOSTON: REVENUE SHARE BY GEOGRAPHY 2017(%)
  • FIGURE 13. CONMED: NET SALES, 2015-2017 ($MILLION)
  • FIGURE 14. CONMED: REVENUE BY SEGMENT, 2016 (%)
  • FIGURE 15. CONMED: NET SALES, 2015-2017 ($MILLION)
  • FIGURE 16. MEDTRONIC: NET SALES, 2015-2017($MILLION)
  • FIGURE 17. MEDTRONIC: REVENUE SHARE PER SEGMENT 2017(%)
  • FIGURE 18. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY 2017(%)
  • FIGURE 19. SMITH & NEPHEW: NET SALES, 2015-2017($MILLION)
  • FIGURE 20. SMITH & NEPHEW: REVENUE SHARE PER SEGMENT 2017(%)
  • FIGURE 21. SMITH & NEPHEW: REVENUE SHARE BY GEOGRAPHY 2017(%)
  • FIGURE 22. STRYKER: NET SALES, 2015-2017($MILLION)
  • FIGURE 23. STRYKER: REVENUE SHARE BY SEGMENT, 2017 (%)
  • FIGURE 24. STRYKER: REVENUE SHARE BY GEOGRAPHY, 2017(%)
目次
Product Code: LI_184705

Endoscopic RFA is an advanced treatment modality, which is commonly applied in the treatment of medical indication such as uncoordinated heartbeats, Barrett's esophagus, and pain management, and others. Radiofrequency ablation is considered to be an FDA-approved advanced endoscopic technique in which the diseased tissue is exposed to heat energy for its destruction or removal. The global endoscope + radiofrequency ablation (RFA) market was valued at $3,567.4 million in 2017 and is estimated to reach at $7,471.5 million by 2025, registering a CAGR of 9.6% from 2018 to 2025.

Upsurge in geriatric population that is highly susceptible to pain and chronic disorders has a positive impact on the market growth. In addition, rise in need for the development of advanced minimally invasive surgical techniques has propelled the demand for endoscopic RFA across healthcare settings, thus fueling the market growth.

However, dearth of skilled professionals that lack complete know-how of endoscopic RFA treatment impedes the market growth. Conversely, high untapped potential in the emerging economies is anticipated to offer significant profitable opportunities for the expansion of the market.

The endoscope + radiofrequency ablation (RFA) market is segmented based on application. On the basis of application, the market is categorized into cardiology applications, pain management, oncology applications, and others.

KEY BENEFITS

  • This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of global endoscope + radiofrequency ablation (RFA) market.
  • Market size and estimations are based on comprehensive analysis of the applications and developments in the industry.
  • A qualitative analysis based on innovative products and devices facilitate the strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

KEY MARKET SEGMENTS

By Application

  • Cardiology Applications
  • Pain Management
  • Oncology Applications
  • Other Applications

KEY MARKET PLAYERS

  • Boston Scientific Corporation
  • Conmed Corporation
  • Medtronic Plc.
  • Smith & Nephew Plc.
  • Stryker Corporation

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key benefits for stakeholders
  • 1.3. Key market segments
    • 1.3.1. List of key players profiled in the report
  • 1.4. Research methodology
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. Key findings of the study
    • 2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Endoscope + radiofrequency ablation (RFA) market: Innovative products
    • 3.2.1. Barex 360
    • 3.2.2. Habib EUS RFA catheter
    • 3.2.3. Temperature-resistant probes
  • 3.3. Clinical trials: RFA and RFA + endoscope products in pipeline
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in the prevalence of cancer and cardiac ailments across the globe
      • 3.4.1.2. Large scale adoption of endoscopic RFA devices in pain management
      • 3.4.1.3. High efficacy and short duration of the procedure
    • 3.4.2. Restraints
      • 3.4.2.1. High costs associated with the RFA treatment
      • 3.4.2.2. Limited awareness regarding available RFA + endoscope devices
    • 3.4.3. Opportunity
      • 3.4.3.1. Emerging indications for the endoscopic radiofrequency ablation

CHAPTER 4: ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET, BY APPLICATION

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Oncology application
    • 4.2.1. Market size and forecast
  • 4.3. Pain management
    • 4.3.1. Market size and forecast
  • 4.4. Cardiology application
    • 4.4.1. Market size and forecast
  • 4.5. Other applications
    • 4.5.1. Market size and forecast

CHAPTER 5: COMPANY PROFILES

  • 5.1. Boston Scientific Corporation
    • 5.1.1. Company overview
    • 5.1.2. Company snapshot
    • 5.1.3. Operating business segment
    • 5.1.4. Business performance
    • 5.1.5. Key strategic moves and developments
  • 5.2. Conmed Corporation
    • 5.2.1. Company overview
    • 5.2.2. Company snapshot
    • 5.2.3. Operating business segment
    • 5.2.4. Business performance
    • 5.2.5. Key strategic moves and developments
  • 5.3. Medtronic Plc
    • 5.3.1. Company overview
    • 5.3.2. Company snapshot
    • 5.3.3. Operating business segment
    • 5.3.4. Business performance
    • 5.3.5. Key strategic moves and developments
  • 5.4. Smith & Nephew Plc
    • 5.4.1. Company overview
    • 5.4.2. Company snapshot
    • 5.4.3. Operating business segment
    • 5.4.4. Business performance
  • 5.5. Stryker Corporation
    • 5.5.1. Company overview
    • 5.5.2. Company snapshot
    • 5.5.3. Operating business segments
    • 5.5.4. Business performance
    • 5.5.5. Key strategic moves and developments